<h4>Introduction</h4>Zapnometinib (ATR-002) is a selective MEK inhibitor designed to modulate the MAPK/ERK pathway, which plays a key role in viral infections and inflammatory diseases. The gene discussed is MAP2K7; the disease is viral infectious disease.